PSG NSW presents Building the RNA ecosystem
This webinar is essential viewing for medicinal research scientists in the academic and private sectors as well as manufacturing, QA, laboratory and regulatory personnel in established therapeutic goods organisations.
The recent period of the Covid pandemic has seen many scientific innovations, their development accelerated by the necessity of converting them into products for the diagnosis and treatment of Covid. A major and life saving new product has been the introduction of mRNA based vaccines. The pandemic has also highlighted the current need to import most pharmaceuticals and almost all active ingredients into Australia.
The NSW State Government has initiated and is funding a project to establish a local RNA GMP compliant pilot manufacturing facility to translate mRNA and other RNA research into therapeutics, including vaccines.
The facility will be established in partnership between the NSW State government with NSW and ACT universities through the NSW RNA Bioscience Alliance and will include capabilities for clinical scale manufacturing of mRNA, synthetic oligonucleotides and lipid nanoparticle (LNP) formulation to enable early-stage RNA-based drug development. The NSW RNA Bioscience is led by Prof Pall Thordason of UNSW who is also is Director of the UNSW RNA Institute. The NSW RNA Bioscience Alliance is an alliance between all the NSW and ACT universities to advance the research, development and manufacturing of RNA technologies. The NSW Government and the NSW RNA Bioscience alliance have recently commenced the search for an industry partner to run and operate the proposed RNA Pilot Manufacturing Facility as a key component in the plan to grow a vibrant RNA ecosystem in NSW.
Presenter Prof Pall Thordarson
Director, RNA Institute UNSW
At the webinar Palli will describe, within public domain, the science, objectives and progress of the vaccine facility, challenges met and foreseen and expertise and opportunities required.
This webinar is essential viewing for medicinal research scientists in the academic and private sectors as well as manufacturing, QA, laboratory and regulatory personnel in established therapeutic goods organisations.
The format of the webinar is that the Prof Thordarson will give a 30-45 presentation, followed by a further Q&A session.
More detail about Prof Thordarson and his research can be found at https://newsroom.unsw.edu.au/news/science-tech/he-almost-became-farmer-iceland-now-hes-leading-rna-development-australia.
Prof Thordarson is Present-Elect of the RACI, becoming President in November of this year.
When: Monday 25 July 2022
Where: Via Zoom Conferencing
Time: 4:30PM to 5:30PM AEST
Cost: Free for RACI Members
Non-Members $10
Registrations close at 12 noon, Friday 22 July. Owing to webinar setup activities, later registration applications cannot be accepted. Zoom links will be sent out prior to the webinar starting on the day.
Follow the instructions and which fields to complete as an RACI member or non-member with care. Members with an RACI account should enter their Username and Password and follow subsequent instructions. Non-members will initially need to “Create a new account” and also follow subsequent instructions.